Design and Evolution of an Artificial Aldolase with an Abiological Catalytic Cofactor in Apo-Myoglobin
Organic Letters · 2025
DOI: 10.1021/acs.orglett.5c03309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, 2025. Verfasst von Qinru Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China. Hauptthemen laut MEDLINE: Myoglobin, Fructose-Bisphosphate Aldolase, Aldehyde-Lyases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
- School of Biotechnology, Jiangnan University, Wuxi 214122, China.
ORCID-Profile: Zhi Zhou
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Hu, Q., Feng, L., You, R., Zhu, Z., Lei, J., & Zhou, Z. (2025). Design and Evolution of an Artificial Aldolase with an Abiological Catalytic Cofactor in Apo-Myoglobin. Organic Letters. https://doi.org/10.1021/acs.orglett.5c03309
Vancouver
Hu Q, Feng L, You R, Zhu Z, Lei J, Zhou Z. Design and Evolution of an Artificial Aldolase with an Abiological Catalytic Cofactor in Apo-Myoglobin. Organic Letters. 2025. doi:10.1021/acs.orglett.5c03309
BibTeX
@article{Hu2025,
author = {Hu, Qinru and Feng, Liangyu and You, Ran and Zhu, Zhixi and Lei, Jie and Zhou, Zhi},
title = {Design and Evolution of an Artificial Aldolase with an Abiological Catalytic Cofactor in Apo-Myoglobin},
journal = {Organic Letters},
year = {2025},
doi = {10.1021/acs.orglett.5c03309}
}
EUVIMED